Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model

BACKGROUND: Gaucher disease (GD) is a rare recessively inherited disorder caused by deficiency of a lysosomal enzyme, glucocerebrosidase. Accumulation of glucosylceramide or glucosylsphingosine in macrophages leads to increased production of ferritin and chitotriosidase and to decreases in hemoglobi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigan, Marie, Stirnemann, Jérôme, Caillaud, Catherine, Froissart, Roseline, Boutten, Anne, Fantin, Bruno, Belmatoug, Nadia, Mentré, France
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094900/
https://www.ncbi.nlm.nih.gov/pubmed/24980507
http://dx.doi.org/10.1186/1750-1172-9-95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094900/
https://www.ncbi.nlm.nih.gov/pubmed/24980507
http://dx.doi.org/10.1186/1750-1172-9-95

Ejemplares similares